Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical Co

04/02/2026 06:31

Feb 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             7.31                5.81             10.00    
                 (+25.9 pct)         (+3.9 pct)       (+28.4 pct) 
  Operating        187 mln          loss 341 mln        200 mln   
  Recurring        222 mln          loss 297 mln        250 mln   
  Net              215 mln           loss 19 mln        200 mln   
                                                     (+210.4 pct) 
  EPS             6.19 yen          loss 0.55 yen      5.76 yen   
  Ann Div                             3.00 yen         3.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             3.00 yen         3.00 yen   
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T